User profiles for "author:Deanna Jannat-Khah"
deanna jannat-khahAssistant Scientist HSS; Assistant Professor of Epidemiology in Medicine WCM Verified email at med.cornell.edu Cited by 1348 |
Rituximab, but not other antirheumatic therapies, is associated with impaired serological response to SARS-CoV-2 vaccination in patients with rheumatic diseases
R Spiera, S Jinich, D Jannat-Khah - Annals of the rheumatic diseases, 2021 - ard.bmj.com
There is a paucity of data on the effect of antirheumatic drugs on serological responses to
COVID-19 vaccines. Anti-CD20 therapies deplete B-cells, with reconstitution often not …
COVID-19 vaccines. Anti-CD20 therapies deplete B-cells, with reconstitution often not …
Antimicrobial-Resistant Nocardia Isolates, United States, 1995–2004
KB Uhde, S Pathak, I McCullum Jr… - Clinical infectious …, 2010 - academic.oup.com
We conducted a 10-year retrospective evaluation of the epidemiology and identification of
Nocardia isolates submitted to the Centers for Disease Control and Prevention for …
Nocardia isolates submitted to the Centers for Disease Control and Prevention for …
Systemic rheumatic disease flares after SARS-CoV-2 vaccination among rheumatology outpatients in New York City
M Barbhaiya, JM Levine, VP Bykerk… - Annals of the …, 2021 - ard.bmj.com
Supplemental material This content has been supplied by the author (s). It has not been
vetted by BMJ Publishing Group Limited (BMJ) and may not have been peer-reviewed. Any …
vetted by BMJ Publishing Group Limited (BMJ) and may not have been peer-reviewed. Any …
COVID-19 in hospitalized adults with HIV
K Stoeckle, CD Johnston… - Open Forum …, 2020 - academic.oup.com
Background The spread of SARS-CoV-2 and the COVID-19 pandemic have caused
significant morbidity and mortality worldwide. The clinical characteristics and outcomes of …
significant morbidity and mortality worldwide. The clinical characteristics and outcomes of …
[HTML][HTML] Lower baseline autoantibody levels are associated with immune-related adverse events from immune checkpoint inhibition
N Ghosh, M Postow, C Zhu, D Jannat-Khah… - … for ImmunoTherapy of …, 2022 - ncbi.nlm.nih.gov
Methods This study used data from an oncologic clinical trial of adaptive dosing combination
ICI therapy in patients with advanced melanoma. Plasma was collected at baseline and 6 …
ICI therapy in patients with advanced melanoma. Plasma was collected at baseline and 6 …
Prevalence of misdiagnosis of cellulitis: A systematic review and meta‐analysis
TS Cutler, DP Jannat‐Khah, B Kam… - Journal of Hospital …, 2023 - Wiley Online Library
Background There is no gold standard test to accurately identify patients with cellulitis and
therefore misdiagnosis is common. Using the clinical impression of a dermatology or an …
therefore misdiagnosis is common. Using the clinical impression of a dermatology or an …
Comparative safety and effectiveness of TNF inhibitors, IL6 inhibitors and methotrexate for the treatment of immune checkpoint inhibitor-associated arthritis
AR Bass, N Abdel-Wahab, PD Reid… - Annals of the …, 2023 - ard.bmj.com
Objectives To compare the safety and effectiveness of biologic and conventional disease-
modifying antirheumatic drugs (DMARDs) for immune checkpoint inhibitor-associated …
modifying antirheumatic drugs (DMARDs) for immune checkpoint inhibitor-associated …
Impact of COVID-19 on vulnerable patients with rheumatic disease: results of a worldwide survey
Objective There is emerging evidence that COVID-19 disproportionately affects people from
racial/ethnic minority and low socioeconomic status (SES) groups. Many physicians across …
racial/ethnic minority and low socioeconomic status (SES) groups. Many physicians across …
[HTML][HTML] Machine learning identification of thresholds to discriminate osteoarthritis and rheumatoid arthritis synovial inflammation
Background We sought to identify features that distinguish osteoarthritis (OA) and
rheumatoid arthritis (RA) hematoxylin and eosin (H&E)-stained synovial tissue samples …
rheumatoid arthritis (RA) hematoxylin and eosin (H&E)-stained synovial tissue samples …
[HTML][HTML] Adverse events and disease flares after SARS-CoV-2 vaccination in patients with systemic lupus erythematosus
M Barbhaiya, JM Levine, CH Siegel, VP Bykerk… - Clinical …, 2022 - Springer
Dear Editor, Vaccination against SARS-CoV-2 is particularly important for patients with
systemic lupus erythematosus (SLE), who may be at increased risk of hospitalization from …
systemic lupus erythematosus (SLE), who may be at increased risk of hospitalization from …